Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stenzl

Showing results (701-710 of 927) with videos related to

Pageof 93
Sort By:
Cell Transplantation|January 22, 2015
Regeneration of degenerated urinary sphincter muscles: improved stem cell-based therapies and novel imaging technologiesBastian Amend, Martin Vaegler, Kerstin Fuchs, et al.
World Journal of Urology|August 9, 2011
Akt signalling parameters are different in oncocytomas compared to renal cell carcinomaB Amend, J Hennenlotter, M Scharpf, et al.
Journal of Cancer Research and Clinical Oncology|December 4, 2016
Comparison of different concepts for interpretation of chromosomal aberrations in urothelial cells detected by fluorescence in situ hybridizationJohannes Mischinger, Lutz Philipp Guttenberg, Jörg Hennenlotter, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|December 24, 2016
Robotic intracorporeal urinary diversion: practical review of current surgical techniquesFabrizio Dal Moro, Georges P Haber, Peter Wiklund, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2012
A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human αν integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancerA Heidenreich, S K Rawal, K Szkarlat, et al.
World Journal of Urology|March 31, 2022
T2 mapping for the characterization of prostate lesionsTobias Hepp, Laura Kalmbach, Manuel Kolb, et al.
BJU International|April 16, 2008
Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancerDavid Schilling, Heinz P Schlemmer, Philipp H Wagner, et al.
Cell Reports. Medicine|August 21, 2024
HSD3B1 genotype and outcomes in metastatic hormone-sensitive prostate cancer with androgen deprivation therapy and enzalutamide: ARCHESNima Sharifi, Arun A Azad, Mona Patel, et al.
BMC Cancer|February 19, 2014
Decreased GATA5 mRNA expression associates with CpG island methylation and shortened recurrence-free survival in clear cell renal cell carcinomaInga Peters, Natalia Dubrowinskaja, Michael Kogosov, et al.
Cancer|February 26, 2011
Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy : A multicenter randomized, double-blind, placebo-controlled trialArnulf Stenzl, Hannes Penkoff, Elfriede Dajc-Sommerer, et al.
Pageof 93

Showing results (701-710 of 927) with videos related to

Sort By:
Pageof 93
Cell Transplantation|January 22, 2015
Regeneration of degenerated urinary sphincter muscles: improved stem cell-based therapies and novel imaging technologiesBastian Amend, Martin Vaegler, Kerstin Fuchs, et al.
World Journal of Urology|August 9, 2011
Akt signalling parameters are different in oncocytomas compared to renal cell carcinomaB Amend, J Hennenlotter, M Scharpf, et al.
Journal of Cancer Research and Clinical Oncology|December 4, 2016
Comparison of different concepts for interpretation of chromosomal aberrations in urothelial cells detected by fluorescence in situ hybridizationJohannes Mischinger, Lutz Philipp Guttenberg, Jörg Hennenlotter, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|December 24, 2016
Robotic intracorporeal urinary diversion: practical review of current surgical techniquesFabrizio Dal Moro, Georges P Haber, Peter Wiklund, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2012
A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human αν integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancerA Heidenreich, S K Rawal, K Szkarlat, et al.
World Journal of Urology|March 31, 2022
T2 mapping for the characterization of prostate lesionsTobias Hepp, Laura Kalmbach, Manuel Kolb, et al.
BJU International|April 16, 2008
Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancerDavid Schilling, Heinz P Schlemmer, Philipp H Wagner, et al.
Cell Reports. Medicine|August 21, 2024
HSD3B1 genotype and outcomes in metastatic hormone-sensitive prostate cancer with androgen deprivation therapy and enzalutamide: ARCHESNima Sharifi, Arun A Azad, Mona Patel, et al.
BMC Cancer|February 19, 2014
Decreased GATA5 mRNA expression associates with CpG island methylation and shortened recurrence-free survival in clear cell renal cell carcinomaInga Peters, Natalia Dubrowinskaja, Michael Kogosov, et al.
Cancer|February 26, 2011
Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy : A multicenter randomized, double-blind, placebo-controlled trialArnulf Stenzl, Hannes Penkoff, Elfriede Dajc-Sommerer, et al.
Pageof 93